3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
8
Completed
8
Active not recruiting
6
Withdrawn
5
Terminated
4
Unknown
1
Available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
25
Lymphoid
8
Myeloid
2
Plasma cell
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Graft vs Host Disease
1
Interventions
Dexamethasone
70
Cyclophosphamide
44
Bortezomib
41
Lenalidomide
25
Melphalan
24
Thalidomide
19
pomalidomide
17
daratumumab
14
fludarabine
13
carfilzomib
10
Filgrastim
8
Doxorubicin
8
Busulfan
6
isatuximab
5
Prednisone
5
Peripheral Blood Stem Cell Transplantation
5
Calcium Dobesilate
5
Bendamustine Hydrochloride
5
selinexor
4
sargramostim
4
fludarabine phosphate
4
Surveys and Questionnaires
4
Etoposide
4
Clarithromycin
4
liposomal doxorubicin
3
ixazomib
3
dexamethasone acetate
3
Radiotherapy
3
Neoadjuvant Therapy
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
venetoclax
×
Plasma cell
×
Clear all
NCT05005299
2023-08-01
VICTORY
Melbourne Health
Phase 1
Unknown
18 enrolled